News archive

On June 4, Charles River Laboratories International, Inc. has announced the launch of its Virtual Control Group (VCG) initiative in partnership with Sanofi. The two companies are working together to reduce the use of animals by replacing selected control group animals with appropriate virtual control animals developed from retrospective data sets.

As the non-profit organization FRAME (Fund for the Replacement of Animals in Medical Experiments) based in Nottigham has reported, numerous animal-free researchers are still being asked by editors of scientific journals to supplement resp. confirm their research results with animal experiments, even though these were not part of the study. Otherwise they would not be able to publish their research results there.

The Public-Private Platform for the Prevalidation of Methods to Characterize Endocrine Disruptors (PEPPER) is looking for partner laboratories.

Using large-scale genome-wide association studies, researchers have identified several genes that influence the risk of stroke and cardiovascular disease. Professor Martin Dichgans, Director of the Institute for Stroke and Dementia Research at LMU Hospital and a scientist in the SyNergy Cluster of Excellence, is convinced that genetic information can be used to identify potential targets for drug treatment.

Using the phage display method, Prof. Dr. Susanne Aileen Funke and her team from the Institute of Bioanalytics at Coburg University of Applied Sciences have discovered two new D-peptides, MMD3 and ISADI, which can alter the feared neuro-damaging aggregation of tau proteins.

Swedish researchers from Chalmers University of Technology and Gothenburg University have developed an AI method to better identify toxic chemicals based on molecular structure.

This year, the congress of the European Society for Alternatives to Animal Testing (EUSAAT) will take place at the University of Linz from September 18 - 20.

As reported by Technische Universität Berlin, scientists at TU Berlin have succeeded in producing a model of the liver from human cells using 3D bioprinting without having to resort to materials of any animal origin. Up to now, in vitro research has often relied on fetal calf serum (FCS) as culture medium and laminins or collagens from mice.

This year's laboratory animal of the year is the pig. The Federal Association of People for Animal Rights reports on the various areas in which pigs are used and highlights approaches that could replace or at least reduce animal testing.

The state animal welfare officers with expertise in the field of animal testing and alternatives have established a working group to develop key points for reducing animal testing and switching to animal-free research technologies.